ArticleTherapeutic advances in medical oncology2018

Tumour necrosis factor, interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung cancer: a pragmatic approach in clinical practice.

Efimia Boutsikou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.